Skip to main content
Livermore
Livermore
ZHEN

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

PMVP holding history

PMV Pharmaceuticals, Inc. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PMVP overviewAll 13F holders of PMVPFull Q2 2026 holdings

Shares (Q2 2026)
47,308
Value
$63.4K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of PMVP by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202647,308$63.4K<0.1%+2,260+5.0%AddedHolders
Q1 202645,048$55.9K<0.1%−73,545−62.0%ReducedHolders
Q4 2025118,593$148.2K<0.1%−74,560−38.6%ReducedHolders
Q3 2025193,153$270.4K<0.1%−63,278−24.7%ReducedHolders
Q2 2025256,431$271.8K<0.1%+242,311+1,716.1%AddedHolders
Q1 202514,120$15.4K<0.1%−93,768−86.9%ReducedHolders
Q4 2024107,888$162.9K<0.1%−947,808−89.8%ReducedHolders
Q3 20241,055,696$1.57M<0.1%−660,778−38.5%ReducedHolders
Q2 20241,716,474$2.78M<0.1%+135,924+8.6%AddedHolders
Q1 20241,580,550$2.69M<0.1%+350,200+28.5%AddedHolders
Q4 20231,230,350$3.81M<0.1%−692,007−36.0%ReducedHolders
Q3 20231,922,357$11.8M<0.1%−204,464−9.6%ReducedHolders
Q2 20232,126,821$13.3M<0.1%+346,717+19.5%AddedHolders
Q1 20231,780,104$8.49M<0.1%+404,005+29.4%AddedHolders
Q4 20221,376,099$12.0M<0.1%+406,601+41.9%AddedHolders
Q3 2022969,498$11.5M<0.1%−440,580−31.2%ReducedHolders
Q2 20221,410,078$20.1M<0.1%+1,369,096+3,340.7%AddedHolders
Q1 202240,982$853.0K<0.1%−119,570−74.5%ReducedHolders
Q4 2021160,552$3.71M<0.1%+135,205+533.4%AddedHolders
Q3 202125,347$755.0K<0.1%−101,288−80.0%ReducedHolders
Q2 2021126,635$4.33M<0.1%+116,602+1,162.2%AddedHolders
Q1 202110,033$330.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.